News
Merck signs €1.4bn cancer alliance with China’s Hengrui
Germany’s Merck KGaA has reached a deal with Chinese pharma company …
19787 items found
News
GSK claims a first with Jemperli in endometrial cancer
GSK has built the case for first-line use of its PD-1 inhibitor …
News
EMA finds no evidence GLP-1 agonists cause thyroid cancer
The EMA’s safety committee has said that, after a review of available …
R&D
Clinical trial disparities and how to build a more inclusive future
Historically, clinical trials have lacked diversity amongst both …
Market Access
Sponsored
Localisation: Tailoring global campaigns for local success
When it comes to the pharmaceutical industry, a company’s marketing …
Patients
Deep Dive: Patients and Partnerships 2023
Consent has long been a controversial and complex debate for pharma. …
News
Aiolos $245m Series A heads latest crop of biotech rounds
Biotech investment may be somewhat in the doldrums at the moment, but …
News
Early result backs Regeneron’s deafness gene therapy
Regeneron’s gene therapy for a profound form of deafness affecting …
News
FDA clears Roche’s Vabysmo for retinal vein occlusion
Roche has claimed a third approval from the FDA for its eye disease …
Oncology
News
Lilly finally gets FDA OK for ulcerative colitis drug Omvoh
After an earlier rejection, the FDA has approved Eli Lilly’s …
R&D
Sponsored
Revolutionising research: Inside the NCVR evolution in the UK
On 1st October, the roll-out of the National Contract Value Review …
News
Incyte blocks US launch of Sun Pharma's alopecia drug
A US district court has granted an injunction sought by Incyte on the launch of Sun Pharma's recently approved Leqselvi for alopecia areata.
Digital
Sponsored
The AI effect in pharma commercial strategy: From data to re...
Discover how AI is transforming the pharma commercial strategy. Unlock real-time insights & actions from data. Click here for more.
Sales & Marketing
Deep Dive: Commercialisation 2024
In this issue, we unpack Ozempic’s rise to superstar status and the risks associated with its off-label use.
Digital
Sponsored
How to deal with fragmented data - A $12.9 million challenge
In the age of AI, large data sets – like the treasure trove of customer data most biopharma companies are sitting on – are an invaluable asset.
Digital
A journey from personal to public: Digital health passports ...
A digital health passport is an app, or online certification, that displays a traveller’s health or vaccination record. It can save lives, on both private and public levels.
Sales & Marketing
Sponsored
Launch Excellence: Moments of Truth
The launch environment for pharmaceutical industry products is evolving at pace with new scientific discoveries and shifting engagement patterns, creating challenges and opportunities.
R&D
Partner Content
Europe’s Largest Industry-Led & Dedicated Gathering for mRNA...
The 4th mRNA-Based Therapeutics Summit Europe returns to Frankfurt, Germany as the industry’s premier forum dedicated to showcasing the hottest disease targets,
R&D
Partner Content
Proteomic Based Drug Discovery Summit 2025
Determine Optimum Application of Proteomics to Accelerate Screening of Novel Targets, Unravel the Mode of Action, & Identify Biomarkers to Progress Small Molecule Drug Discovery & T
